Direkt zum Inhalt
Merck

Uptake of different crystal structures of TiO₂ nanoparticles by Caco-2 intestinal cells.

Toxicology letters (2014-03-01)
Constantinos Gitrowski, Aliaa R Al-Jubory, Richard D Handy
ZUSAMMENFASSUNG

The gastrointestinal uptake of different crystal structures of TiO2 was investigated using Caco-2 intestinal cells. Caco-2 monolayers exhibited time-dependent, saturable uptake of Ti from TiO2 exposures of 1 mgl(-1) over 24h, which was influenced by crystal type. Initial uptake rates were 5.3, 3.73, 3.58 and 4.48 nmol mg(-1)protein h(-1) for bulk, P25, anatase and rutile forms respectively. All exposures caused elevations of Ti in the cells relative to the control (ANOVA P<0.05). Electron micrographs of the Caco-2 monolayer showed the presence of particles inside the cells, and energy dispersive spectroscopy (EDS) confirmed the composition as TiO2. Incubating the cells with 120 IU nystatin (putative endocytosis inhibitor) or 100 μmol l(-1) vanadate (ATPase inhibitor) caused large increases in Ti accumulation for all crystal types relative to controls (ANOVA P<0.05), except for the rutile form with vanadate. Incubating the cells with 90 μmol l(-1) genistein (tyrosine kinase inhibitor) or 27 μmol l(-1) chloropromazine (clathrin-mediated endocytosis inhibitor) caused a large decrease in Ti accumulation relative to the controls (ANOVA P<0.05). Cell viability measures were generally good (low LDH leak, normal cell morphology), but there were some changes in the electrolyte composition (K(+), Na(+), Ca(2+), Mg(2+)) of exposed cells relative to controls. A rise in total Ca(2+) concentration in the cells was observed for all TiO2 crystal type exposures. Overall, the data shows that Ti accumulation for TiO2 NP exposure in Caco-2 cells is crystal structure-dependent, and that the mechanism(s) involves endocytosis of intact particles.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Titan(IV)-oxid, nanopowder, 21 nm primary particle size (TEM), ≥99.5% trace metals basis
Sigma-Aldrich
Nystatin-Suspension, suspension, 10,000 unit/mL in DPBS, BioReagent, suitable for cell culture
Sigma-Aldrich
Titan(IV)-oxid, Anatase, nanopowder, <25 nm particle size, 99.7% trace metals basis
Sigma-Aldrich
Titan(IV)-oxid, puriss., meets analytical specification of Ph. Eur., BP, USP, 99-100.5%
Sigma-Aldrich
Titan(IV)-oxid, Anatase, powder, 99.8% trace metals basis
Sigma-Aldrich
Titan(IV)-oxid, ReagentPlus®, ≥99%
Sigma-Aldrich
Genistein, synthetic, ≥98% (HPLC), powder
Sigma-Aldrich
Chlorpromazin -hydrochlorid, ≥98% (TLC)
Sigma-Aldrich
Titan(IV)-oxid, Rutil, powder, <5 μm, ≥99.9% trace metals basis
Sigma-Aldrich
Nystatin, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Titan(IV)-oxid, Anatase, powder, −325 mesh, ≥99% trace metals basis
Sigma-Aldrich
Titan(IV)-oxid, Rutil, nanopowder, <100 nm particle size, 99.5% trace metals basis
Sigma-Aldrich
Nystatin, ≥4,400 USP units/mg
Sigma-Aldrich
Titan(IV)-oxid, Mischung aus Rutil und Anatas, nanopowder, <100 nm particle size (BET), 99.5% trace metals basis
Sigma-Aldrich
Amiloride hydrochloride hydrate, ≥98% (HPLC), powder
Sigma-Aldrich
Nystatin, powder, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
Titan(IV)-oxid, Mischung aus Rutil und Anatas, nanoparticles, <150 nm particle size (volume distribution, DLS), dispersion, 40 wt. % in H2O, 99.5% trace metals basis
Sigma-Aldrich
Titan(IV)-oxid, Rutil, ≥99.98% trace metals basis
USP
Nystatin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Titan(IV)-oxid, Rutil, 99.995% trace metals basis
Sigma-Aldrich
Titan(IV)-oxid, contains 1% Mn as dopant, nanopowder, <100 nm particle size (BET), ≥97%
Sigma-Aldrich
Genistein, from Glycine max (soybean), ~98% (HPLC)
Supelco
Chlorpromazine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Titan(IV)-oxid, nanowires, diam. × L ~100 nm × 10 μm
Sigma-Aldrich
Titan(IV)-oxid, nanowires, diam. × L ~10 nm × 10 μm
Sigma-Aldrich
Titan(IV)-oxid, Rutil, <001>, (single crystal substrate), ≥99.9% trace metals basis, L × W × thickness 10 mm × 10 mm × 0.5 mm
USP
Amilorid -hydrochlorid, United States Pharmacopeia (USP) Reference Standard
Nystatin, European Pharmacopoeia (EP) Reference Standard
Supelco
Genistein, analytical standard
Sigma-Aldrich
Chlorpromazin -hydrochlorid, meets USP testing specifications